Treatment approaches and biomarkers PRevalence In de novo MEtastatic hormone-sensitive prostate cancer in Russian Federation

Trial Identifier:	D133HR00058
Sponsor:	AstraZeneca
Start Date:	June 2025
Primary Completion Date:	June 2027
Study Completion Date:	June 2027
Condition:	Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.